On Oct 26, 2021 DNA Script closed a Series C round and raised $165,000,000 from Agilent Technologies, Alexandria Venture Investments, ArrowMark Partners, Bpifrance, Casdin Capital, Catalio Capital Management, Coatue, Columbia Threadneedle Investments, Danaher Life Science, Farallon Capital Management, Fidelity Management and Research Company, Illumina Ventures, Kurma Partners, Life Sciences Partners, M Ventures, Moore Strategic Ventures, featuring lead investors Catalio Capital Management, Coatue.
About the company: DNA Script is located at France, Europe.
“Discover DNA Script’s proprietary Enzymatic DNA Synthesis (EDS) technology, including the SYNTAX System, the world’s first DNA printer powered by EDS.”
Company website: http://www.dnascript.com
